142 related articles for article (PubMed ID: 23455792)
1. Low grade follicular lymphoma with high proliferation index; diagnostic and management issues.
Das S; Basu D; Dubashi B; Jain A
Indian J Pathol Microbiol; 2012; 55(4):516-8. PubMed ID: 23455792
[TBL] [Abstract][Full Text] [Related]
2. Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up.
Czuczman MS; Weaver R; Alkuzweny B; Berlfein J; Grillo-López AJ
J Clin Oncol; 2004 Dec; 22(23):4711-6. PubMed ID: 15483015
[TBL] [Abstract][Full Text] [Related]
3. [Occurrence of follicular small cleaved cell lymphoma following chemotherapy for diffuse large cell lymphoma].
Saito S; Hayashi K; Ohnoshi T; Kawashima K; Matsutomo S; Tagawa S; Yoshino T; Nishiuchi R; Kimura I
Rinsho Ketsueki; 1994 Jul; 35(7):676-81. PubMed ID: 8065020
[TBL] [Abstract][Full Text] [Related]
4. A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas.
Sinha R; Kaufman JL; Khoury HJ; King N; Shenoy PJ; Lewis C; Bumpers K; Hutchison-Rzepka A; Tighiouart M; Heffner LT; Lechowicz MJ; Lonial S; Flowers CR
Cancer; 2012 Jul; 118(14):3538-48. PubMed ID: 22535574
[TBL] [Abstract][Full Text] [Related]
5. [Composite lymphoma consisting of Hodgkin lymphoma and follicular lymphoma].
Uchida T; Sugimoto K; Koike M
Rinsho Ketsueki; 2009 Feb; 50(2):83-6. PubMed ID: 19265299
[TBL] [Abstract][Full Text] [Related]
6. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
Nickenig C; Dreyling M; Hoster E; Pfreundschuh M; Trumper L; Reiser M; Wandt H; Lengfelder E; Unterhalt M; Hiddemann W;
Cancer; 2006 Sep; 107(5):1014-22. PubMed ID: 16878325
[TBL] [Abstract][Full Text] [Related]
7. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
8. A unique composite follicular lymphoma and mantle cell lymphoma with a mixed cell pattern and aggressive course.
Liu Y; Li P; Guo Y; Fan L; Wang L; Zhu J; Huang G; Yan Q; Wang Z
Am J Clin Pathol; 2014 May; 141(5):737-41. PubMed ID: 24713749
[TBL] [Abstract][Full Text] [Related]
9. Follicular lymphoma transforming to DLBCL and reverting back to follicular lymphoma at relapse-a case report.
Suresh Babu MC; Thottian AGF; Lokanatha D; Jacob LA; Lokesh KN; Rudresha AH; Rajeev LK; Smitha S; Hassan SA; Ashok KP; Premalatha CS; Suma MN
J Egypt Natl Canc Inst; 2020 May; 32(1):22. PubMed ID: 32410046
[TBL] [Abstract][Full Text] [Related]
10. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
[TBL] [Abstract][Full Text] [Related]
11. PET/CT Assessment of Follicular Lymphoma and High Grade B Cell Lymphoma - Good Correlation with Clinical and Histological Features at Diagnosis.
Novelli S; Briones J; Flotats A; Sierra J
Adv Clin Exp Med; 2015; 24(2):325-30. PubMed ID: 25931367
[TBL] [Abstract][Full Text] [Related]
12. Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Watanabe R; Tomita N; Kishimoto K; Koyama S; Ogusa E; Ishii Y; Miyashita K; Matsuura S; Fujisawa S; Hattori Y; Takasaki H; Fujita A; Ohshima R; Kuwabara H; Hashimoto C; Fujimaki K; Sakai R; Ishigatsubo Y
Leuk Res; 2013 Oct; 37(10):1208-12. PubMed ID: 23927994
[TBL] [Abstract][Full Text] [Related]
13. Signal transducers and activators of transcription 5a-dependent cross-talk between follicular lymphoma cells and tumor microenvironment characterizes a group of patients with improved outcome after R-CHOP.
Taskinen M; Valo E; Karjalainen-Lindsberg ML; Hautaniemi S; Meri S; Leppä S
Clin Cancer Res; 2010 May; 16(9):2615-23. PubMed ID: 20388848
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of the intra-follicular tumor cell proliferative rate in follicular lymphoma.
Koster A; Tromp HA; Raemaekers JM; Borm GF; Hebeda K; Mackenzie MA; van Krieken JH
Haematologica; 2007 Feb; 92(2):184-90. PubMed ID: 17296567
[TBL] [Abstract][Full Text] [Related]
15. Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group.
Klapper W; Hoster E; Rölver L; Schrader C; Janssen D; Tiemann M; Bernd HW; Determann O; Hansmann ML; Möller P; Feller A; Stein H; Wacker HH; Dreyling M; Unterhalt M; Hiddemann W; Ott G;
J Clin Oncol; 2007 Aug; 25(22):3330-6. PubMed ID: 17664481
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
[TBL] [Abstract][Full Text] [Related]
17. Composite lymphoma arising in the parotid gland: a case report.
Urano M; Mizoguchi Y; Nishio T; Abe M; Kuroda M; Saito S; Sakurai K
Auris Nasus Larynx; 2004 Mar; 31(1):89-93. PubMed ID: 15041061
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of primary mediastinal large B-cell lymphomas].
Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
[TBL] [Abstract][Full Text] [Related]
19. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
[TBL] [Abstract][Full Text] [Related]
20. Indolent Lymphomas That Present With Clinically Aggressive Features: A Subset of Low-Grade Lymphomas With a Behavior Inconsistent With the Histologic Diagnosis.
Cabanillas F; Rivera N; Pardo WI
Clin Lymphoma Myeloma Leuk; 2016 Oct; 16(10):550-557. PubMed ID: 27618361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
